[1]
Hassan Farooq, Uzair Naeem and Riva Khan 2025. Ensifentrine, a novel dual phosphodiesterase 3 and 4 inhibitor in the treatment of chronic obstructive pulmonary disease. Journal of the Pakistan Medical Association. 76, 01 (Dec. 2025), 128–128. DOI:https://doi.org/10.47391/JPMA.31152.